Putting theories and results into practice: Managing cases

Quan Dong Nguyen, Diana V. Do, Julia A. Haller, Jeffrey S. Heier, Peter K. Kaiser

Research output: Contribution to journalArticle

Abstract

The following are highlights from a case discussion, which was moderated by the Course Director, Quan Dong Nguyen, MD, MSc. The faculty reviewed 3 case studies and discussed their different approaches to managing the treatment of each patient. They also fielded questions from audience members about their management suggestions and the potential US Food and Drug Administration approval of aflibercept, which was not approved at the time of this discussion. In addition, the 2-year CATT (Comparison of Age-Related Macular Degeneration Treatments Trials) results and 1-year IVAN (Inhibit Vascular Endothelial Growth Factor in Age-Related Choroidal Neovascularization) results were not released at the time this discussion took place.

Original languageEnglish (US)
Pages (from-to)S16-S22
JournalOphthalmology
Volume120
Issue number5 SUPPL.
DOIs
StatePublished - May 2013

Fingerprint

Drug Approval
Choroidal Neovascularization
Macular Degeneration
Vascular Endothelial Growth Factor A
Food
Therapeutics
aflibercept

ASJC Scopus subject areas

  • Ophthalmology

Cite this

Nguyen, Q. D., Do, D. V., Haller, J. A., Heier, J. S., & Kaiser, P. K. (2013). Putting theories and results into practice: Managing cases. Ophthalmology, 120(5 SUPPL.), S16-S22. https://doi.org/10.1016/j.ophtha.2013.01.060

Putting theories and results into practice : Managing cases. / Nguyen, Quan Dong; Do, Diana V.; Haller, Julia A.; Heier, Jeffrey S.; Kaiser, Peter K.

In: Ophthalmology, Vol. 120, No. 5 SUPPL., 05.2013, p. S16-S22.

Research output: Contribution to journalArticle

Nguyen, QD, Do, DV, Haller, JA, Heier, JS & Kaiser, PK 2013, 'Putting theories and results into practice: Managing cases', Ophthalmology, vol. 120, no. 5 SUPPL., pp. S16-S22. https://doi.org/10.1016/j.ophtha.2013.01.060
Nguyen QD, Do DV, Haller JA, Heier JS, Kaiser PK. Putting theories and results into practice: Managing cases. Ophthalmology. 2013 May;120(5 SUPPL.):S16-S22. https://doi.org/10.1016/j.ophtha.2013.01.060
Nguyen, Quan Dong ; Do, Diana V. ; Haller, Julia A. ; Heier, Jeffrey S. ; Kaiser, Peter K. / Putting theories and results into practice : Managing cases. In: Ophthalmology. 2013 ; Vol. 120, No. 5 SUPPL. pp. S16-S22.
@article{3069e499fed24f19aae4c965d9bae0e7,
title = "Putting theories and results into practice: Managing cases",
abstract = "The following are highlights from a case discussion, which was moderated by the Course Director, Quan Dong Nguyen, MD, MSc. The faculty reviewed 3 case studies and discussed their different approaches to managing the treatment of each patient. They also fielded questions from audience members about their management suggestions and the potential US Food and Drug Administration approval of aflibercept, which was not approved at the time of this discussion. In addition, the 2-year CATT (Comparison of Age-Related Macular Degeneration Treatments Trials) results and 1-year IVAN (Inhibit Vascular Endothelial Growth Factor in Age-Related Choroidal Neovascularization) results were not released at the time this discussion took place.",
author = "Nguyen, {Quan Dong} and Do, {Diana V.} and Haller, {Julia A.} and Heier, {Jeffrey S.} and Kaiser, {Peter K.}",
year = "2013",
month = "5",
doi = "10.1016/j.ophtha.2013.01.060",
language = "English (US)",
volume = "120",
pages = "S16--S22",
journal = "Ophthalmology",
issn = "0161-6420",
publisher = "Elsevier Inc.",
number = "5 SUPPL.",

}

TY - JOUR

T1 - Putting theories and results into practice

T2 - Managing cases

AU - Nguyen, Quan Dong

AU - Do, Diana V.

AU - Haller, Julia A.

AU - Heier, Jeffrey S.

AU - Kaiser, Peter K.

PY - 2013/5

Y1 - 2013/5

N2 - The following are highlights from a case discussion, which was moderated by the Course Director, Quan Dong Nguyen, MD, MSc. The faculty reviewed 3 case studies and discussed their different approaches to managing the treatment of each patient. They also fielded questions from audience members about their management suggestions and the potential US Food and Drug Administration approval of aflibercept, which was not approved at the time of this discussion. In addition, the 2-year CATT (Comparison of Age-Related Macular Degeneration Treatments Trials) results and 1-year IVAN (Inhibit Vascular Endothelial Growth Factor in Age-Related Choroidal Neovascularization) results were not released at the time this discussion took place.

AB - The following are highlights from a case discussion, which was moderated by the Course Director, Quan Dong Nguyen, MD, MSc. The faculty reviewed 3 case studies and discussed their different approaches to managing the treatment of each patient. They also fielded questions from audience members about their management suggestions and the potential US Food and Drug Administration approval of aflibercept, which was not approved at the time of this discussion. In addition, the 2-year CATT (Comparison of Age-Related Macular Degeneration Treatments Trials) results and 1-year IVAN (Inhibit Vascular Endothelial Growth Factor in Age-Related Choroidal Neovascularization) results were not released at the time this discussion took place.

UR - http://www.scopus.com/inward/record.url?scp=84876986948&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84876986948&partnerID=8YFLogxK

U2 - 10.1016/j.ophtha.2013.01.060

DO - 10.1016/j.ophtha.2013.01.060

M3 - Article

C2 - 23642782

AN - SCOPUS:84876986948

VL - 120

SP - S16-S22

JO - Ophthalmology

JF - Ophthalmology

SN - 0161-6420

IS - 5 SUPPL.

ER -